Zhonghua Xue Ye Xue Za Zhi. 2024 Jan 14;45(1):8-17. doi: 10.3760/cma.j.cn121090-20231107-00253.
Extramedullary plasmacytoma (EMP) is a special type of malignant plasmacytosis, which is complex and heterogeneous. Most EMP patients have poor prognosis and lack a stratified prognostic system or ideal treatment strategy supported by evidence-based medical evidence, which cannot meet clinical needs. In order to improve the understanding of this disease entity, Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association and Chinese Myeloma Committee-Chinese Hematology Association developed the "Chinese Expert Consensus on the diagnosis and treatment of extramedullary plasmacytoma", which aims to standardize the clinical diagnosis and treatment of EMP and ultimately improve the overall survival of patients with plasmacytoma.
髓外浆细胞瘤（EMP）是一种特殊类型的恶性浆细胞增多症，其具有复杂性和异质性。大多数EMP患者预后较差，缺乏分层的预后系统或循证医学证据支持的理想治疗策略，无法满足临床需求。为提高对这一疾病实体的认识，中华医学会血液学分会浆细胞疾病学组、中国骨髓瘤委员会-中华血液学会制定了《髓外浆细胞瘤诊断与治疗中国专家共识》，旨在规范EMP的临床诊断与治疗，最终提高浆细胞瘤患者的总生存率。
